Browse by Title

Type here to filter the list

M
Management of EMD and plasma cell leukemia

Laura Rosinol, MD, PhD (she/her/hers) – Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain ### 1395063###Speaker###Amyloidosis and Myeloma Unit, Department of Hematology###Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain###
Speaker: Laura Rosinol, MD, PhD (she/her/hers) – Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain
### she/her/hers
Managing acute immunotherapy complications

Krina K. Patel, MD (she/her/hers) – MD Anderson Cancer Center, University of Texas, Houston, TX, USA ### 1395098###Speaker###Associate Professor###MD Anderson Cancer Center, University of Texas, Houston, TX, USA###
Speaker: Krina K. Patel, MD (she/her/hers) – MD Anderson Cancer Center, University of Texas, Houston, TX, USA
### she/her/hers
Managing CAR T Cell Therapies in the Real World

Yi Lin, MD, PHD – Mayo Clinic, Rochester, MN, USA ### 1395155###Speaker###Associate Professor###Mayo Clinic, Rochester, MN, USA###
Speaker: Yi Lin, MD, PHD – Mayo Clinic, Rochester, MN, USA
###
Managing the older, frail patient with multiple co-morbidities

Salomon Manier, MD, PhD – Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France ### 1395123###Speaker###Professor of Medicine###Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France###
Speaker: Salomon Manier, MD, PhD – Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France
###
Meet the Professor: Approaches to MRD assessment

Ajay K. Nooka, MD, MPH (he/him/his) – Winship Cancer Institute, Emory University School of Medicine ### 1395064###Speaker###Professor, Department of Hematology and Medical Oncology###Winship Cancer Institute, Emory University School of Medicine###
Speaker: Ajay K. Nooka, MD, MPH (he/him/his) – Winship Cancer Institute, Emory University School of Medicine
### he/him/his @@@ Suzanne Trudel, MD – Princess Margaret Cancer Centre, Toronto, ON, Canada ### 1395092###Speaker###Professor of Medicine###Princess Margaret Cancer Centre, Toronto, ON, Canada###
Speaker: Suzanne Trudel, MD – Princess Margaret Cancer Centre, Toronto, ON, Canada
###
Meet the Professor: Artificial intelligence in myeloma: what would its utility be?

Marta Sonia González, MD (she/her/hers) – H CLINICO UNIVERSITARIO SANTIAGO DE COMPOSTELA ### 1954269###Speaker###HEMATOLOGIST###H CLINICO UNIVERSITARIO SANTIAGO DE COMPOSTELA###
Speaker: Marta Sonia González, MD (she/her/hers) – H CLINICO UNIVERSITARIO SANTIAGO DE COMPOSTELA
### she/her/hers @@@ Claudio Cerchione, MD, PhD (he/him/his) – Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy ### 1661147###Speaker###Clinician###Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy###
Speaker: Claudio Cerchione, MD, PhD (he/him/his) – Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
### he/him/his
Meet the Professor: Assessing QOL and PRO measures

Tanya Wildes, MD, MSCI (she/her/hers) – University of Nebraska Medical Center/Nebraska Medicine ### 1954266###Speaker###Associate Professor of Medicine###University of Nebraska Medical Center/Nebraska Medicine###
Speaker: Tanya Wildes, MD, MSCI (she/her/hers) – University of Nebraska Medical Center/Nebraska Medicine
### she/her/hers @@@ Raphael Szalat, MD; PhD (he/him/his) – Boston University Chobanian & Avedisian School of Medicine ### 1442373###Speaker###Assistant professor of Medicine###Boston University Chobanian & Avedisian School of Medicine###
Speaker: Raphael Szalat, MD; PhD (he/him/his) – Boston University Chobanian & Avedisian School of Medicine
### he/him/his
Meet the Professor: Castlemans and POEMS

Angela Dispenzieri, MD – Mayo Clinic Rochester ### 1395071###Speaker###Professor, Division of Hematology, Department of Internal Medicine###Mayo Clinic Rochester###
Speaker: Angela Dispenzieri, MD – Mayo Clinic Rochester
### @@@ Frits van Rhee, MD PHD (he/him/his) – Myeloma Center, University of Arkansas of Medicine ### 1954268###Speaker###Professor of Medicine###Myeloma Center, University of Arkansas of Medicine###
Speaker: Frits van Rhee, MD PHD (he/him/his) – Myeloma Center, University of Arkansas of Medicine
### he/him/his
Meet the Professor: Clonal hematopoiesis in myeloma: implications for therapy

Enrique M. Ocio, MD, PhD – Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain ### 1409099###Speaker###Head of the Hematology Department###Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain###
Speaker: Enrique M. Ocio, MD, PhD – Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
### @@@ Adam S. Sperling, MD, PhD (he/him/his) – Brigham and Women's Hospital ### 1395133###Speaker###Assistant Professor###Brigham and Women's Hospital###
Speaker: Adam S. Sperling, MD, PhD (he/him/his) – Brigham and Women's Hospital
### he/him/his
Meet the Professor: Diagnostic approach to a monoclonal protein (lab-based)

Dave Murray, MD PhD – Mayo Clinic ### 1395052###Speaker###Consultant###Mayo Clinic###
Speaker: Dave Murray, MD PhD – Mayo Clinic
### @@@ Joan Bladé, MD PhD – Amyloidosis and Myeloma Unit. Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona. Barcelona, Spain ### 1441772###Speaker###Hematologist###Amyloidosis and Myeloma Unit. Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona. Barcelona, Spain###
Speaker: Joan Bladé, MD PhD – Amyloidosis and Myeloma Unit. Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona. Barcelona, Spain
###
Meet the Professor: Laboratory assessment of immune function

David Avigan, MD (he/him/his) – Beth Israel Deaconess Medical Center ### 1395158###Speaker###Chief, Division of Hematology and Hematologic Malignancies; Cancer Center Director, Beth Israel Deaconess Medical Center; Senior Vice President of Cancer Service, Beth Israel Lahey Health ###Beth Israel Deaconess Medical Center###
Speaker: David Avigan, MD (he/him/his) – Beth Israel Deaconess Medical Center
### he/him/his @@@ Heinz Ludwig, MD – Department of Medicine I, Wilhelminen Cancer Research Institute, Klinik Ottakring ### 1442243###Speaker###Head of Institute###Department of Medicine I, Wilhelminen Cancer Research Institute, Klinik Ottakring###
Speaker: Heinz Ludwig, MD – Department of Medicine I, Wilhelminen Cancer Research Institute, Klinik Ottakring
###
Meet the Professor: Light chain amyloidosis

Ashutosh D. Wechalekar, MD – University College Hospital ### 1441901###Speaker###Professor of Medicine and Haematology###University College Hospital###
Speaker: Ashutosh D. Wechalekar, MD – University College Hospital
### @@@ Vaishali Sanchorawala, MD (she/her/hers) – Boston University Chobanian & Avedisian School of Medicine ### 1395067###Speaker###Director, Amyloidosis Center,### Boston University Chobanian & Avedisian School of Medicine###
Speaker: Vaishali Sanchorawala, MD (she/her/hers) – Boston University Chobanian & Avedisian School of Medicine
### she/her/hers
Meet the Professor: Management of bone disease

Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center ### 1442036###Speaker###Clinical Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###
Speaker: Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center
###
Meet the Professor: Managing renal failure in MM

Efstathios Kastritis, MD, PhD (he/him/his) – National and Kapodistrian University of Athens ### 1949897###Speaker###Professor of Medicine ###National and Kapodistrian University of Athens ###
Speaker: Efstathios Kastritis, MD, PhD (he/him/his) – National and Kapodistrian University of Athens
### he/him/his @@@ Pankaj Malhorta, MD – Postgraduate Institute of Medical Education and Research ### 1949879###Speaker###Professor and Head###Postgraduate Institute of Medical Education and Research###
Speaker: Pankaj Malhorta, MD – Postgraduate Institute of Medical Education and Research
###
Meet the Professor: Neuropathy and MGUS

Jorge J. Castillo, MD (he/him/his) – Dana-Farber Cancer Institute ### 1416879###Speaker###Associate Professor of Medicine###Dana-Farber Cancer Institute###
Speaker: Jorge J. Castillo, MD (he/him/his) – Dana-Farber Cancer Institute
### he/him/his @@@ Andrew R. Branagan, MD, PhD – Massachusetts General Hospital ### 1442194###Speaker###Attending Physician###Massachusetts General Hospital###
Speaker: Andrew R. Branagan, MD, PhD – Massachusetts General Hospital
###
Meet the Professor: Optimal imaging approaches in MM

Elena Zamagni, Sr., MD, PhD (she/her/hers) – European Myeloma Network, Italy ### 1395050###Speaker###Investigator###European Myeloma Network, Italy###
Speaker: Elena Zamagni, Sr., MD, PhD (she/her/hers) – European Myeloma Network, Italy
### she/her/hers @@@ Jens Hillengass, MD, PhD – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA ### 1409085###Speaker###Professor of Oncology and Internal Medicine###Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA###
Speaker: Jens Hillengass, MD, PhD – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
###
Meet the Professor: Optimizing in vitro cellular models of MM

Mariateresa Fulciniti, PhD – Dana Farber Cancer Institute ### 1949886###Speaker###Lead Scientist###Dana Farber Cancer Institute###
Speaker: Mariateresa Fulciniti, PhD – Dana Farber Cancer Institute
### @@@ Niccolo Bolli, Prof. – University of Milan ### 1949887###Speaker###Associate Professor of Hematology###University of Milan###
Speaker: Niccolo Bolli, Prof. – University of Milan
###
Meet the Professor: Proteomic evaluation in MM

Constantine S. Mitsiades, MD, PhD – Dana Farber Cancer Institute ### 1409098###Speaker###Associate Professor in Medicine###Dana Farber Cancer Institute###
Speaker: Constantine S. Mitsiades, MD, PhD – Dana Farber Cancer Institute
### @@@ Manoj Bhasin, PhD – Emory University ### 1395127###Speaker###Director of Genomics, Proteomics, Bioinformatics and Systems Biology at Children’s Healthcare of Atlanta. ###Emory University###
Speaker: Manoj Bhasin, PhD – Emory University
###
Meet the Professor: Racial disparity: impact and solutions

Lalit Kumar, MD, DM (he/him/his) – Oncology and BMT, Artemis Hospitals, Gurugram122001, India ### 1443208###Speaker###Chairperson###Oncology and BMT, Artemis Hospitals, Gurugram122001, India###
Speaker: Lalit Kumar, MD, DM (he/him/his) – Oncology and BMT, Artemis Hospitals, Gurugram122001, India
### he/him/his @@@ Craig E. Cole, MD – Michigan State University-Karmanos Cancer Institute ### 1395102###Speaker###Assistant Professor###Michigan State University-Karmanos Cancer Institute###
Speaker: Craig E. Cole, MD – Michigan State University-Karmanos Cancer Institute
###
Meet the Professor: Risk stratified follow up of MGUS and SMM

Meral Beksac, MD (she/her/hers) – Ankara University ### 1443293###Speaker###Professor of Hematology###Ankara University###
Speaker: Meral Beksac, MD (she/her/hers) – Ankara University
### she/her/hers @@@ Natalie Callander, MD – University of Wisconsin ### 1949893###Speaker###Director, Myeloma Clinical Program###University of Wisconsin###
Speaker: Natalie Callander, MD – University of Wisconsin
###
Meet the Professor: Single cell genomic techniques for study of myeloma

Samir Parekh, MD – Mount Sinai Medical Center, New York, NY, USA ### 1441821###Speaker###Professor of Medicine, Hematology-Oncology & Oncological Sciences###Mount Sinai Medical Center, New York, NY, USA###
Speaker: Samir Parekh, MD – Mount Sinai Medical Center, New York, NY, USA
### @@@ Brian A. Walker, PhD (he/him/his) – Indiana University ### 1395036###Speaker###Professor###Indiana University###
Speaker: Brian A. Walker, PhD (he/him/his) – Indiana University
### he/him/his
Meet the Professor: Solitary tumor plasmacytoma

Carlos Fernandez de Larrea, MD, PhD – Hospital Clínic de Barcelona ### 1949895###Speaker###Consultant, Amyloidosis and Myeloma Unit, Department of Hematology###Hospital Clínic de Barcelona###
Speaker: Carlos Fernandez de Larrea, MD, PhD – Hospital Clínic de Barcelona
### @@@ Andrzej J. Jakubowiak, MD, PhD – University of Chicago, Chicago, IL, USA ### 1409087###Speaker###Professor of Medicine; Director, Myeloma Program###University of Chicago, Chicago, IL, USA###
Speaker: Andrzej J. Jakubowiak, MD, PhD – University of Chicago, Chicago, IL, USA
###
Meet the Professor: Understanding the concept of MGRS

Nelson Leung, MD – Division of hematology and Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN ### 1395109###Speaker###Consultant###Division of hematology and Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN###
Speaker: Nelson Leung, MD – Division of hematology and Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN
###
Meet the Professor: Vaccination and infection prevention

Karthik Ramasamy, MBBS FRCP FRCPath PhD – University of Oxford and Oxford University Hospitals NHS FT ### 1949894###Speaker###Associate Professor & Consultant Haematologist###University of Oxford and Oxford University Hospitals NHS FT###
Speaker: Karthik Ramasamy, MBBS FRCP FRCPath PhD – University of Oxford and Oxford University Hospitals NHS FT
### @@@ Dorotea Fantl, MD – Hospital Italiano de Buenos Aires, Argentina. ### 1409082###Speaker###Consultant Physician in the Hematology Department of the Hospital Italiano de Buenos Aires ###Hospital Italiano de Buenos Aires, Argentina.###
Speaker: Dorotea Fantl, MD – Hospital Italiano de Buenos Aires, Argentina.
###
Meet the Professor: Waldenstrom macroglobulinemia

Prashant Kapoor, MD – Mayo Clinic ### 1395070###Speaker###Consultant/Associate Professor of Medicine ###Mayo Clinic###
Speaker: Prashant Kapoor, MD – Mayo Clinic
### @@@ Veronique Leblond, MD (she/her/hers) – Sorbonne Université ### 1954265###Speaker###Professeur emerite###Sorbonne Université ###
Speaker: Veronique Leblond, MD (she/her/hers) – Sorbonne Université
### she/her/hers
Metabolomic alterations defining disease progression in myeloma

Mala Shanmugam, MS, PhD (she/her/hers) – Winship Cancer Institute, Emory University ### 1395131###Speaker###Associate Professor###Winship Cancer Institute, Emory University###
Speaker: Mala Shanmugam, MS, PhD (she/her/hers) – Winship Cancer Institute, Emory University
### she/her/hers
Molecular characterization and therapeutic targeting of protein kinase D2 in T(414) multiple myeloma

Raphael Szalat, MD; PhD (he/him/his) – Boston University Chobanian & Avedisian School of Medicine ### 1442373###Speaker###Assistant professor of Medicine###Boston University Chobanian & Avedisian School of Medicine###
Speaker: Raphael Szalat, MD; PhD (he/him/his) – Boston University Chobanian & Avedisian School of Medicine
### he/him/his
Molecular determinants of drug resistance

Lawrence Boise, PhD (he/him/his) – Emory University ### 1949882###Speaker###Professor###Emory University###
Speaker: Lawrence Boise, PhD (he/him/his) – Emory University
### he/him/his
Molecular drivers of extramedullary progression

Moritz Binder, MD MPH (he/him/his) – Mayo Clinic ### 1718954###Speaker###Senior Associate Consultant###Mayo Clinic###
Speaker: Moritz Binder, MD MPH (he/him/his) – Mayo Clinic
### he/him/his
MRD and CLL

Paolo Ghia, MD. PhD (he/him/his) – Università Vita-Salute San Raffaele ### 2075353###Speaker###Professor of Medical Oncology###Università Vita-Salute San Raffaele###
Speaker: Paolo Ghia, MD. PhD (he/him/his) – Università Vita-Salute San Raffaele
### he/him/his